Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vaccines

Free Subscription 26.11.2018 2 Clin Infect Dis 3 J Infect Dis 1 J Pediatr 1 J Virol 1 Lancet Public Health 3 Lancet Respir Med 1 Pediatrics 1 PLoS One 2 Proc Natl Acad Sci U S A 27 Vaccine 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Clin Infect Dis

1. LOEVINSOHN G, Rosman L, Moss WJ
   Measles Seroprevalence and Vaccine Responses in HIV-Infected Adolescents and Adults: A Systematic Review.
   Clin Infect Dis. 2018 Nov 17. pii: 5188002. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
2. KOLDITZ M, Schmitt J, Pletz MW, Tesch F, et al
   Impact of the 13-valent pneumococcal conjugate vaccine on incidence of all-cause pneumonia in adults aged >/= 60 years - a population-based retrospective cohort study.
   Clin Infect Dis. 2018 Nov 21. pii: 5194155. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

3. GERSHON AA, Brooks D, Stevenson DD, Chin WK, et al
   High Constitutive IL-10 Interferes with the Immune Response to Varicella-Zoster Virus (VZV) in Elderly Recipients of Live Attenuated Zoster Vaccine.
   J Infect Dis. 2018 Nov 16. pii: 5184646. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
4. FINN A
   The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence.
   J Infect Dis. 2018 Nov 16. pii: 5184715. doi: 10.1093.
   PubMed     Text format    
   
   
5. POETSCH JH, Dahlke C, Zinser ME, Kasonta R, et al
   Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans.
   J Infect Dis. 2018 Nov 17. pii: 5187947. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Pediatr

6. LU PJ, Yankey D, Fredua B, O'Halloran AC, et al
   Association of Provider Recommendation and Human Papillomavirus Vaccination Initiation among Male Adolescents Aged 13-17 Years-United States.
   J Pediatr. 2018 Nov 15. pii: S0022-3476(18)31541.
   PubMed     Text format     Abstract available
   
   

   
   J Virol

7. MONTICELLI SR, Earley AK, Tate J, Ward BM, et al
   The Ectodomain of the Vaccinia Virus Glycoprotein A34 is Required for Cell Binding by Extracellular Virions and Contains a Large Region Capable of Interaction with the Glycoprotein B5.
   J Virol. 2018 Nov 21. pii: JVI.01343-18. doi: 10.1128/JVI.01343.
   PubMed     Text format     Abstract available
   
   

   
   Lancet Public Health

8. CASTANON A, Landy R, Pesola F, Windridge P, et al
   Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study.
   Lancet Public Health. 2018;3:e34-e43.
   PubMed     Text format     Abstract available
   
   

   
   Lancet Respir Med

9. FENG S, Chiu SS, Chan ELY, Kwan MYW, et al
   Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study.
   Lancet Respir Med. 2018 Nov 12. pii: S2213-2600(18)30419.
   PubMed     Text format     Abstract available
   
   
10. BURKI TK
    Concerns over low uptake of flu vaccination in social care.
    Lancet Respir Med. 2018 Nov 12. pii: S2213-2600(18)30471.
    PubMed     Text format    
    
    
11. DO LAH, Mulholland K
    How long are children protected by influenza vaccination?
    Lancet Respir Med. 2018 Nov 12. pii: S2213-2600(18)30463.
    PubMed     Text format    
    
    

    
    Pediatrics

12. WILLIAMS JTB, Nussbaum AM
    Minister to Their Instruction: Revisiting the Minister-Vaccinator Rowland Hill.
    Pediatrics. 2018 Nov 20. pii: peds.2018-1021. doi: 10.1542/peds.2018-1021.
    PubMed     Text format    
    
    

    
    PLoS One

13. MARX M, Zumpe M, Troschke-Meurer S, Shah D, et al
    Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice.
    PLoS One. 2018;13:e0207320.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

14. FINK AL, Engle K, Ursin RL, Tang WY, et al
    Biological sex affects vaccine efficacy and protection against influenza in mice.
    Proc Natl Acad Sci U S A. 2018 Nov 19. pii: 1805268115.
    PubMed     Text format     Abstract available
    
    
15. POGORELYY MV, Minervina AA, Touzel MP, Sycheva AL, et al
    Precise tracking of vaccine-responding T cell clones reveals convergent and personalized response in identical twins.
    Proc Natl Acad Sci U S A. 2018 Nov 20. pii: 1809642115.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

16. ESPOSITO S, Principi N
    Herpes zoster prevention: A difficult problem to solve.
    Vaccine. 2018;36:5442-5448.
    PubMed     Text format     Abstract available
    
    
17. VENKATRAMAN N, Silman D, Folegatti PM, Hill AVS, et al
    Vaccines against Ebola virus.
    Vaccine. 2018;36:5454-5459.
    PubMed     Text format     Abstract available
    
    
18. WILKINS AL, Snape MD
    Emerging clinical experience with vaccines against group B meningococcal disease.
    Vaccine. 2018;36:5470-5476.
    PubMed     Text format     Abstract available
    
    
19. POLAND GA, Ovsyannikova IG, Kennedy RB
    Personalized vaccinology: A review.
    Vaccine. 2018;36:5350-5357.
    PubMed     Text format     Abstract available
    
    
20. KOWALZIK F, Faber J, Knuf M
    MMR and MMRV vaccines.
    Vaccine. 2018;36:5402-5407.
    PubMed     Text format     Abstract available
    
    
21. OBANDO-PACHECO P, Rivero-Calle I, Gomez-Rial J, Rodriguez-Tenreiro Sanchez C, et al
    New perspectives for hexavalent vaccines.
    Vaccine. 2018;36:5485-5494.
    PubMed     Text format     Abstract available
    
    
22. LUCERO Y, Vidal R, O'Ryan G M
    Norovirus vaccines under development.
    Vaccine. 2018;36:5435-5441.
    PubMed     Text format     Abstract available
    
    
23. DATTA SS, O'Connor PM, Jankovic D, Muscat M, et al
    Progress and challenges in measles and rubella elimination in the WHO European Region.
    Vaccine. 2018;36:5408-5415.
    PubMed     Text format     Abstract available
    
    
24. BONANNI P, Zanella B, Santomauro F, Lorini C, et al
    Safety and perception: What are the greatest enemies of HPV vaccination programmes?
    Vaccine. 2018;36:5424-5429.
    PubMed     Text format     Abstract available
    
    
25. PRYMULA R, Shaw J, Chlibek R, Urbancikova I, et al
    Vaccination in newly arrived immigrants to the European Union.
    Vaccine. 2018;36:5385-5390.
    PubMed     Text format     Abstract available
    
    
26. BEN-SHIMOL S, Givon-Lavi N, Grisaru-Soen G, Megged O, et al
    Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
    Vaccine. 2018;36:5477-5484.
    PubMed     Text format     Abstract available
    
    
27. MAVER PJ, Poljak M
    Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review.
    Vaccine. 2018;36:5416-5423.
    PubMed     Text format     Abstract available
    
    
28. BONANNI P, Bonaccorsi G, Lorini C, Santomauro F, et al
    Focusing on the implementation of 21st century vaccines for adults.
    Vaccine. 2018;36:5358-5365.
    PubMed     Text format     Abstract available
    
    
29. SEPPALA EM, Lopez-Perea N, Torres de Mier MV, Echevarria JE, et al
    Last cases of rubella and congenital rubella syndrome in Spain, 1997-2016: The success of a vaccination program.
    Vaccine. 2018 Nov 16. pii: S0264-410X(18)31539.
    PubMed     Text format     Abstract available
    
    
30. TUCKERMAN J, Misan S, Salih S, Joseph Xavier B, et al
    Influenza vaccination: Uptake and associations in a cross-sectional study of children with special risk medical conditions.
    Vaccine. 2018 Nov 16. pii: S0264-410X(18)31299.
    PubMed     Text format     Abstract available
    
    
31. DONG B, Wang L, Nie S, Li X, et al
    Anti-glioma effect of intracranial vaccination with tumor cell lysate plus flagellin in mice.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)30550.
    PubMed     Text format     Abstract available
    
    
32. NAGASHIMA S, Yamamoto C, Ko K, Chuon C, et al
    Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31541.
    PubMed     Text format     Abstract available
    
    
33. MILLIGAN GN, Schnierle BS, McAuley AJ, Beasley DWC, et al
    Defining a correlate of protection for chikungunya virus vaccines.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31399.
    PubMed     Text format     Abstract available
    
    
34. BIELECKI K, Kirolos A, Willocks LJ, Pollock KG, et al
    Low uptake of nasal influenza vaccine in polish and other ethnic minority children in Edinburgh, Scotland.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31552.
    PubMed     Text format     Abstract available
    
    
35. ESPOSITO D, Titievsky L, Beachler DC, Hawes JCL, et al
    Incidence of outcomes relevant to vaccine safety monitoring in a US commercially-insured population.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31418.
    PubMed     Text format     Abstract available
    
    
36. KUROVA N, Timofeeva EV, Guiso N, Macina D, et al
    A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31516.
    PubMed     Text format     Abstract available
    
    
37. YUE X, Black CL, Williams WW, Lu PJ, et al
    Influenza vaccination among adults living with persons at high-risk for complications from influenza during early 2016-17 influenza season.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31499.
    PubMed     Text format     Abstract available
    
    
38. VALENTINI S, Santoro G, Baffetta F, Franceschi S, et al
    Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31469.
    PubMed     Text format     Abstract available
    
    
39. KAHN KE, Santibanez TA, Zhai Y, Bridges CB, et al
    Association between patient reminders and influenza vaccination status among children.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31395.
    PubMed     Text format     Abstract available
    
    
40. BACCI JL, Hansen R, Ree C, Reynolds MJ, et al
    The effects of vaccination forecasts and value-based payment on adult immunizations by community pharmacists.
    Vaccine. 2018 Nov 13. pii: S0264-410X(18)31540.
    PubMed     Text format     Abstract available
    
    
41. PAN WK, Seidman JC, Ali A, Hoest C, et al
    Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies.
    Vaccine. 2018 Nov 12. pii: S0264-410X(18)30746.
    PubMed     Text format     Abstract available
    
    
42. DIAMOS AG, Larios D, Brown L, Kilbourne J, et al
    Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen.
    Vaccine. 2018 Nov 17. pii: S0264-410X(18)31544.
    PubMed     Text format     Abstract available
    
    

    
    Virus Res

43. KUBLIN JL, Whitney JB
    Zika Virus Research Models.
    Virus Res. 2017 Aug 12. pii: S0168-1702(17)30622.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: